Menu Search
Equities

Aquarius Surgical Technologies Inc

AQQRF:PKC

Aquarius Surgical Technologies Inc

Actions
  • Price (USD)0.0042
  • Today's Change0.00 / 0.00%
  • Shares traded3.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 14 2023 19:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aquarius Surgical Technologies Inc. is a Canada-based provider of minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Its solutions also include clinical education, service, support and maintenance. The Company is primary focused on the development, sale, distribution, marketing and exploitation of technologies for use in surgical environments. It is involved in lasers and fibers sales and service operations through its subsidiary Surgical Lasers Inc. (SLI). SLI is an international distributor, service, support and training organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ear nose throat (ENT), cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment.

  • Revenue in CAD (TTM)207.41k
  • Net income in CAD-641.58k
  • Incorporated1986
  • Employees--
  • Location
    Aquarius Surgical Technologies Inc89 Scollard StreetTORONTO M5R 1G4CanadaCAN
  • Phone+1 (902) 496-7594
  • Fax+1 (902) 484-7599
  • Websitehttps://aquariussurgical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.